Technology

Discover scalable, instrument-free single cell sequencing technology from Parse Bioscience

Technology Overview


Resources

Explore our collection of resources to learn more about technology and its applications from leading researchers

Resources Overview

Company

Providing researchers single cell sequencing with unprecedented scale and ease

About Parse

Parse Biosciences at AGBT 2025: Limits are for Other People

They say hindsight is 20/20. Bill Gates was once (allegedly) quoted as saying, “740 MB of RAM ought to be enough for anybody.” Today, we know better. The same is true for single cell research—what once seemed like a limitation is now just the starting line. At Parse, we’re redefining what’s possible, pushing past old constraints to empower researchers with unprecedented scale and flexibility.

Thank you for joining us at the 2025 AGBT General Meeting. We can’t wait to see you next year, but the conversation doesn’t have to wait until then. Reach out to our team of experts today to discuss scalable single cell sequencing for your research projects!

Sessions

Sponsorship Talk

Ushering in a new era of biological discovery with scaled up single cell sequencing

Parse Biosciences Co-founder and Chief Technology Officer outlines the latest advances in the original combinatorial barcoding technology, Evercode.

Charlie Roco, PhD
Charlie Roco, PhD
CTO and Cofounder
Parse Biosciences

Poster Presentations

Targeted transcriptome sequencing of up to one million immune cells allows identification of rare cell types at low cost

English